Concepedia

Jonas Goretzko

JG

Statistics

Publications

7

Citations

355

H-Index

7

Active since

2019

Affiliations

University of Münster(Current)

Institute of Molecular Biology

Motion Control (United States)

Center for Clinical Research (United States)

University Hospital Münster

Jonas Goretzko is an author at University of Münster specializing in drug discovery, immunology, and medicine.

ORCID

Top concepts

Publications per year

2019–2023

7

Publications

7

Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine

Sebastian Schloer, Linda Brunotte, Jonas Goretzko et al. · Emerging Microbes & Infections · 2020 · 152 citations · Full text

, , +22

The clinically licensed antifungal drug itraconazole inhibits influenza virus <i>in vitro</i> and <i>in vivo</i>

Sebastian Schloer, Jonas Goretzko, Alexander Kühnl et al. · Emerging Microbes & Infections · 2019 · 64 citations · Full text

, , +18

High Nuclease Activity of Long Persisting Staphylococcus aureus Isolates Within the Airways of Cystic Fibrosis Patients Protects Against NET-Mediated Killing

Susann Herzog, Felix Dach, Nicole de Buhr et al. · Frontiers in Immunology · 2019 · 37 citations · Full text

Pharmacologically induced endolysosomal cholesterol imbalance through clinically licensed drugs itraconazole and fluoxetine impairs Ebola virus infection <i>in vitro</i>

Susann Kummer, Angelika Lander, Jonas Goretzko et al. · Emerging Microbes & Infections · 2021 · 36 citations · Full text

Combinatory Treatment with Oseltamivir and Itraconazole Targeting Both Virus and Host Factors in Influenza A Virus Infection

Sebastian Schloer, Jonas Goretzko, Stephan Pleschka et al. · Viruses · 2020 · 30 citations · Full text

1–5 of 7